The Pap test and Bethesda 2014.

作者信息

Nayar Ritu, Wilbur David C

机构信息

Department of Pathology, Northwestern University, Feinberg School of Medicine, Northwestern Medicine, Chicago, Illinois.

Departments of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

出版信息

Cancer Cytopathol. 2015 May;123(5):271-81. doi: 10.1002/cncy.21521. Epub 2015 May 1.

DOI:10.1002/cncy.21521

PMID:25931431

Abstract

摘要

相似文献

[1]

The Pap test and Bethesda 2014.

Cancer Cytopathol. 2015-5

[2]

A selection of monitoring parameters for gynecologic cytology-Beacons of light for quality assurance.

Cancer Cytopathol. 2014-1

[3]

Screening test results associated with cancer diagnoses in 287 women with cervical squamous cell carcinoma.

Arch Pathol Lab Med. 2012-8-20

[4]

The official nomenclature and terminologies in diagnostic cytopathology: history, evolution, applicability and future.

Ann Pathol. 2012-12

[5]

Updates in Cervical Cytology: The 90-Year-Long Journey from Battle Creek to Today.

Surg Pathol Clin. 2018-9

[6]

Human papillomavirus reporting: impact on Bethesda cytology reports.

Arch Pathol Lab Med. 2003-8

[7]

Primary human papillomavirus screening for cervical cancer in the United States-US Food and Drug Administration approval, clinical trials, and where we are today.

Cancer Cytopathol. 2014-10

[8]

Atypical glandular cells and risk of cervical cancer.

Lancet Oncol. 2016-3

[9]

Case records of the Massachusetts General Hospital. Case 16-2014. A 46-year-old woman in Botswana with postcoital bleeding.

N Engl J Med. 2014-5-22

[10]

Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria.

Cancer. 2008-6-25

引用本文的文献

[1]

Risk Assessment of Precancers and Cancers in Women with Atypical Glandular Cells of Endocervical, Endometrial, and Unknown Origin.

J Cancer. 2025-7-11

[2]

HPV Infection Prevalence, Vaccination-Related Knowledge, Attitudes, and Barriers Among Women Aged 30-64 in Shenzhen, China: A Cross-Sectional Study.

Vaccines (Basel). 2025-5-25

[3]

Immunocytochemical staining for p16, Ki-67, and MCM2 in the detection of cervical lesions and cancer: a prospective observational study.

Transl Cancer Res. 2025-5-30

[4]

A comparative study of 5-aminolevulinic acid photodynamic therapy and loop electrosurgical excision procedure in the treatment of cervical high grade squamous intraepithelial lesions.

Lasers Med Sci. 2025-6-17

[5]

Evaluating HPV E6/E7 mRNA expression and genotype prevalence in cervical cytology and biopsy samples from Yunnan Province, China.

Ecancermedicalscience. 2025-4-17

[6]

Assessment of risk factors for high-grade cervical or endometrial lesions to triage women with AGC-FN: a retrospective study.

BMC Womens Health. 2025-5-28

[7]

Minimally invasive diagnosis of precancerous cervical lesions using single-cell peripheral immune atlas.

Cell Rep Med. 2025-6-17

[8]

German-Austrian guideline on screening for anal dysplasia and anal carcinoma in people living with HIV.

J Dtsch Dermatol Ges. 2025-8

[9]

Haplotype Structures and -318 C>T (rs5742909) Genetic Variant Contribute to the Susceptibility of HPV Infection and Cervical Cancer.

Viruses. 2025-3-21

[10]

A low-cost platform for automated cervical cytology: addressing health and socioeconomic challenges in low-resource settings.

Front Med Technol. 2025-3-31

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

The Pap test and Bethesda 2014.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献